Non-homogeneous liver distribution of photosensitizer and its consequence for photodynamic therapy outcome

Photodiagnosis and Photodynamic Therapy - Tập 7 - Trang 189-200 - 2010
José Dirceu Vollet-Filho1, Mônica Andrioli Caracanhas1, Clóvis Grecco1, Juliana Ferreira2, Cristina Kurachi1, Vanderlei Salvador Bagnato1
1Instituto de Física de São Carlos, Universidade de São Paulo, Av Trabalhador São-carlense, 400, CEP 13566-590, São Carlos, SP, Brazil
2Instituto de Pesquisa e Desenvolvimento, Universidade Vale do Paraíba, Av. Shishima Hifumi, 2911, CEP 12244-000, São José dos Campos, SP, Brazil

Tài liệu tham khảo

Loschenov, 2000, Photodynamic therapy and fluorescence diagnostics, Laser Phys, 10, 1188 Yu, 2006, Real-time in situ monitoring of human prostate photodynamic therapy with diffuse light, Photochem Photobiol, 82, 1279, 10.1562/2005-10-19-RA-721 Wolfsen, 2005, Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus, J Clin Gastroenterol, 39, 189, 10.1097/01.mcg.0000152748.56902.02 Vittar, 2002, Promotion of photodynamic therapy-induced death—laboratory experimental methodology, Biochem Mol Biol Edu, 30, 303, 10.1002/bmb.2002.494030050118 Niedre, 2003, In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy, Cancer Res, 63, 7986 Dougherty, 1987, Photosensitizers—therapy and detection of malignant-tumors, Photochem Photobiol, 45, 879, 10.1111/j.1751-1097.1987.tb07898.x Kurachi, 2003, Photodynamic therapy in the treatment of oral lesions, J Dent Res, 82, 217 Muller, 2006, Photodynamic therapy of brain tumors—a work in progress, Laser Surg Med, 38, 384, 10.1002/lsm.20338 Zhu, 2005, Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy, J Photochem Photobiol B, 79, 231, 10.1016/j.jphotobiol.2004.09.013 Grossweiner, 1997, PDT light dosimetry revisited, J Photochem Photobiol B, 38, 258, 10.1016/S1011-1344(96)07469-6 Dougherty, 1998, Photodynamic therapy, J Natl Cancer I, 90, 889, 10.1093/jnci/90.12.889 Patterson, 1990, In vivo tests of the concept of photodynamic threshold dose in normal rat-liver photosensitized by aluminum chlorosulfonated phthalocyanine, Photochem Photobiol, 51, 343, 10.1111/j.1751-1097.1990.tb01720.x Cheung, 2003, Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model, J Biomed Opt, 8, 248, 10.1117/1.1560011 Jones, 2003, Photodynamic therapy effect of m-THPC (Foscan (R)) in vivo: correlation with pharmacokinetics, Br J Cancer, 89, 398, 10.1038/sj.bjc.6601101 Cauchon, 2006, Photodynamic activity of substituted zinc trisulfophthalocyanines: role of plasma membrane damage, Photochem Photobiol, 82, 1712, 10.1111/j.1751-1097.2006.tb09835.x Lee, 2003, Spatial heterogeneity and temporal kinetics of photosensitizer (AlPcS2) concentration in murine tumors RIF-1 and MTG-B, Photochem Photobiol Sci, 2, 145, 10.1039/b207598a Zuluaga, 1999, Fluorescence excitation emission matrices of human tissue: a system for in vivo measurement and method of data analysis, Appl Spectrosc, 53, 302, 10.1366/0003702991946695 Georgakoudi, 2002, NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of epithelial precancerous changes, Cancer Res, 62, 682 Badizadegan, 2004, Spectroscopic diagnosis and imaging of invisible pre-cancers, Faraday Discuss, 126, 265, 10.1039/b305410a Sokolov, 2002, Optical spectroscopy for detection of neoplasia, Curr Opin Chem Biol, 6, 651, 10.1016/S1367-5931(02)00381-2 Wagnieres, 1998, In vivo fluorescence spectroscopy and imaging for oncological applications, Photochem Photobiol, 68, 603, 10.1111/j.1751-1097.1998.tb02521.x Ramanujam, 2000, Fluorescence spectroscopy in vivo, 20 Melo, 2004, Pharmacokinetics of Photogem using fluorescence monitoring in Wistar rats, J Photochem Photobiol B, 73, 183, 10.1016/j.jphotobiol.2003.11.005 Bellnier, 2006, Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophor-bide-a (Photochlor) and 5-ALA-induced protoporphyrin IX, Laser Surg Med, 38, 439, 10.1002/lsm.20340 Diagaradjane, 2002, In vivo pharmacokinetics of delta-aminolevulinic acid-induced protoporphyrin IX during pre- and post-photodynamic therapy in 7,12-dimethylbenz(a)nthracene-treated skin carcinogenesis in swiss mice: a comparison by three-compartment model, Photochem Photobiol, 76, 81, 10.1562/0031-8655(2002)076<0081:IVPOAA>2.0.CO;2 Ferreira J. Análise da necrose em tecidos normais fotossensibilizados pós Terapia Fotodinâmica—Estudo in vivo. Thesis (Master's degree). Medical School of Ribeirao Preto, University of Sao Paulo; 2003. Zhou, 2006, Tumor vascular area correlates with photosensitizer uptake: analysis of verteporfin microvascular delivery in the Dunning rat prostate tumor, Photochem Photobiol, 82, 1348, 10.1562/2006-03-25-RA-858 Ferreira, 2007, Experimental determination of threshold dose in photodynamic therapy in normal rat liver, Laser Phys Lett, 4, 469, 10.1002/lapl.200710014 Swokowski, 1994 Bogaards, 2007, In vivo quantification of fluorescent molecular markers in real-time: a review to evaluate the performance of five existing methods, Photodiagn Photodyn, 4, 170, 10.1016/j.pdpdt.2007.02.003